Brainsway’s Deep TMS therapy has been widely tested in over 60 clinical studies, for various clinical indications, in leading institutions worldwide. The FDA has cleared this TMS therapy for treatment resistant depression and it is currently available in the U.S., Europe, and South America.
Brainsway’s Deep TMS has been proven to be safe and generally well tolerated. The treatment does not cause any systemic side effects, which are the effects generated by medication entering the bloodstream and circulating throughout the body, such as insomnia, weight gain and sexual dysfunction. The most common side effect is temporary, mild pain or discomfort in the area of the treatment site, which occurs during the TMS therapy session. This typically occurs only during the first week of TMS treatment. Other side effects may include muscle twitching and jaw pain.
Deep TMS therapy should not be used if the patient has metal implants in or around the head (except for standard amalgam dental fillings).